1. Review the clinical significance of long term survival data of the novel therapies in relapsed/refractory ALL
2. Understand how treatment decisions are made given the patient profile and risk factors
3. Discuss the different approaches and strategies in mitigating the risks and managing adverse events
Wednesday, April 14, 2021 7:00 PM EST - 8:00 PM EST
Dr. Elias Jabbour
Dr. Hassan Sibai
This webinar has been made possible through sponsorship from Pfizer
Registration is complimentary and restricted to healthcare professionals. Please click the button below to register:
About the Speaker and Chair
Bio Coming Soon!
For questions, please email firstname.lastname@example.org.